European S1 guidelines on the management of lichen planus: a cooperation of the European Dermatology Forum with the European Academy of Dermatology and Venereology
- PMID: 32678513
- DOI: 10.1111/jdv.16464
European S1 guidelines on the management of lichen planus: a cooperation of the European Dermatology Forum with the European Academy of Dermatology and Venereology
Abstract
Lichen planus (LP) is a chronic inflammatory and immune-mediated disease that affects the skin, hair, nails and mucous membranes. Although there is a broad clinical spectrum of lichen planus manifestations, the skin and oral cavity remain the major sites of involvement. A group of European dermatologists with a long-standing interest and expertise in lichen planus has sought to define therapeutic guidelines for the management of patients with LP. The clinical features, diagnosis and possible medications that clinicians can use, in order to control the disease, will be reviewed in this manuscript. The revised final version of the lichen planus guideline was passed on to the European Dermatology Forum (EDF) for a final consensus with the European Academy of Dermatology and Venereology (EADV).
© 2020 European Academy of Dermatology and Venereology.
References
-
- Kanwar AJ, De D. Lichen planus in children. Indian J Dermatol Venereol Leprol 2010; 76:366-372.
-
- Giuliani M, Troiano G, Cordaro M et al. Rate of malignant transformation of oral lichen planus: A systematic review. Oral Dis 2019; 25: 693-709.
-
- Le Cleach L, Chosidow O. Clinical practice. Lichen planus. N Engl J Med 2012; 366: 723-732.
-
- McCartan BE, Healy CM. The reported prevalence of oral lichen planus: a review and critique. J Oral Pathol Med 2008; 37: 447-453.
-
- Friedl TK, Flaig MJ, Ruzicka T, Rupec RA. Verrucous squamous cell carcinoma complicating hypertrophic lichen planus. Three case reports and review of the literature. Hautarzt 2011; 62: 40-45.
MeSH terms
LinkOut - more resources
Full Text Sources